NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.61% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 5.58% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.42% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.85% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.63% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.50% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.21% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.18% |
| XNCR | Xencor Inc | Healthcare | Biotechnology | 4.00% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.97% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.79% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 3.77% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.71% |
| MNKD | MannKind Corp | Healthcare | Biotechnology | 3.70% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.47% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.44% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.39% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.20% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |